CRAC intermediate 1
CRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors, detailed information can be found in Patent WO 2010122089 A1, intermediate 9.
Product Specifications
CAS Number
[1249343-86-9]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
CRAC Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/CRAC-intermediate-1.html
Concentration
10mM
Purity
98.46
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C(C1=C(F)C=CC=C1F)NC2=NNC=C2
Molecular Formula
C10H7F2N3O
Molecular Weight
223.18
Precautions
H302, H315, H319, H335
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6278028-01 0.1 mL
BCL7B, CT (BCL7B, B Cell CLL/lymphoma 7 protein family member B, Allergen=Hom s 3) (MaxLight 550)
Ask
View Details 
MBS6278028-02 5x 0.1 mL
BCL7B, CT (BCL7B, B Cell CLL/lymphoma 7 protein family member B, Allergen=Hom s 3) (MaxLight 550)
Ask
View Details 043984-FITC 200 µL
ZAP70, NT (ZAP70, SRK, Tyrosine-protein kinase ZAP-70, 70kD zeta-chain associated protein, Syk-related tyrosine kinase) (FITC) discontinued
Ask
View Details 